<DOC>
	<DOCNO>NCT01327300</DOCNO>
	<brief_summary>The purpose study find whether treat patient diarrhea predominant Irritable Bowel Syndrome ( IBS ) anti-inflammatory drug call Mesalamine help improve symptom diarrhea , bloat abdominal pain .</brief_summary>
	<brief_title>Efficacy Mesalamine Diarrhea-predominant Irritable Bowel Syndrome ( dIBS )</brief_title>
	<detailed_description>Irritable bowel syndrome ( IBS ) common gastrointestinal disorder affect 20 % United States population comprise almost 50 % referral gastroenterology practice . Although pathophysiology IBS poorly understand , recently , inflammation increase intestinal permeability identify potential factor etiology diarrhea-predominant IBS patient ( dIBS ) . Despite potential inflammatory etiology IBS , study examine efficacy anti-inflammatory agent mesalamine patient IBS . The primary objective study determine efficacy Apriso™ ( Salix Pharmaceuticals Inc ) , long-acting mesalamine , treatment patient dIBS . Apriso™ , mesalamine approve Food Drug Administration ( FDA ) October 31 , 2008 maintenance remission patient active , mild moderate ulcerative colitis . The investigator perform randomize , double-blind , cross-over trial mesalamine compare placebo patient dIBS . This study analyze objective subjective measure improvement IBS symptom . The subjective measure include improvement overall symptom severity score Global Improvement Scale ( GIS ) objective measure include histological measure inflammation well improvement intestinal membrane permeability treat subject . The investigator demonstrate 12 week treatment period mesalamine , subject improvement overall symptom score , GIS score , reduction intestinal inflammation also prohibit likely improvement Intestinal membrane permeability .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Male female age 1865 year old Functional Bowel Disorder Severity Index Score 37 Normal complete blood count , liver function study renal function study Serologies do rule Celiac Spure patient prior negative EGD small bowel biopsy negative Infectious diarrhea rule stool study Negative colonoscopy Any history chronic liver disease , heart disease , pulmonary renal disease Abnormal EKG Women positive pregnancy test Patient steroid , antacid , warfarin chronic pain condition fibromyalgia Patients drink 2oz alcohol/day regular basis Any cause diarrhea IBD , microscopic colitis , celiac disease , history abdominal obstruction , pancreatitis , ileus , gastrointestinal bleeding . Patients active malignancy past five year Patient history hypersensitivity reaction salicylate contain medication due crosssensitivity mesalamine allergy mesalamine medication past Any subject fibromyalgia exclude pain test portion History Phenylketonuria due aspartame contain Apriso</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Irritable Bowel Syndrome Treatment</keyword>
	<keyword>Mesalamine</keyword>
	<keyword>Anti-inflammatory drug</keyword>
	<keyword>5-ASA drug</keyword>
	<keyword>Apriso ™</keyword>
</DOC>